TG Therapeutics Competitors and Similar CompaniesClear all
TG Therapeutics's competitors and similar companies include CSL Behring.
 TG Therapeutics TG Therapeutics is a biopharmaceutical company, which develops agents for the treatment of hematologic malignancies and autoimmune disorders. | ||
Founding Date | Founding Date 1993 | Founding Date 1904 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations New York, US HQ | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more |
Employees | Employees 15314% increase | Employees 7,5692% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) $616.3m (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) |
Gross profit | Gross profit $515.6m (FY, 2025) | Gross profit $4.5b (FY, 2020) |
For sources of this data, please see the company profile